Ha seleccionado la visión en Inglés
| Descriptor en español: |
Antineoplásicos
| ||||||
| Descriptor en inglés: | Antineoplastic Agents | ||||||
| Descriptor en portugués: | Antineoplásicos | ||||||
| Descriptor en francés: | Antinéoplasiques | ||||||
| Término(s) alternativo(s): |
Agent, Anticancer Agent, Antineoplastic Agent, Antitumor Agent, Cancer Chemotherapy Agents, Anticancer Agents, Antineoplastic Agents, Antitumor Agents, Cancer Chemotherapy Agents, Chemotherapeutic Anticancer Anticancer Agent Anticancer Agents Antineoplastic Antineoplastic Agent Antineoplastic Drug Antineoplastic Drugs Antineoplastics Antitumor Agent Antitumor Agents Antitumor Drug Antitumor Drugs Cancer Chemotherapy Agent Cancer Chemotherapy Agents Cancer Chemotherapy Drug Cancer Chemotherapy Drugs Chemotherapeutic Anticancer Agents Chemotherapeutic Anticancer Drug Chemotherapy Agent, Cancer Chemotherapy Agents, Cancer Chemotherapy Drug, Cancer Chemotherapy Drugs, Cancer Drug, Antineoplastic Drug, Antitumor Drug, Cancer Chemotherapy Drug, Chemotherapeutic Anticancer Drugs, Antineoplastic Drugs, Antitumor Drugs, Cancer Chemotherapy |
||||||
| Código(s) jeráquico(s): |
D27.505.954.248 |
||||||
| Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D000970 | ||||||
| Nota de alcance: | Substances that inhibit or prevent the proliferation of NEOPLASMS. |
||||||
| Nota de indización: | /admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+ |
||||||
| Calificadores permitidos: |
AD administration & dosage AE adverse effects AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Versión alternativa: | ANTINEOPL AGENTS |
||||||
| Vea también los descriptores: |
Anticarcinogenic Agents
MeSH Chemoembolization, Therapeutic MeSH Chemotherapy, Cancer, Regional Perfusion MeSH Cytotoxins MeSH Infusions, Intra-Arterial MeSH Tumor Lysis Syndrome MeSH | ||||||
| Identificador de DeCS: | 974 | ||||||
| ID del Descriptor: | D000970 | ||||||
| Clasificación de la NLM: | QV 269 | ||||||
| Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
| Fecha de establecimiento: | 01/01/1966 | ||||||
| Fecha de entrada: | 01/01/1999 | ||||||
| Fecha de revisión: | 27/05/2020 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
|
Antineoplastic Agents
- Concepto preferido
| UI del concepto |
M0001483 |
| Nota de alcance | Substances that inhibit or prevent the proliferation of NEOPLASMS. |
| Término preferido | Antineoplastic Agents |
| Término(s) alternativo(s) |
Agent, Anticancer Agent, Antineoplastic Agent, Antitumor Agent, Cancer Chemotherapy Agents, Anticancer Agents, Antineoplastic Agents, Antitumor Agents, Cancer Chemotherapy Agents, Chemotherapeutic Anticancer Anticancer Agent Anticancer Agents Antineoplastic Antineoplastic Agent Antineoplastic Drug Antineoplastic Drugs Antineoplastics Antitumor Agent Antitumor Agents Antitumor Drug Antitumor Drugs Cancer Chemotherapy Agent Cancer Chemotherapy Agents Cancer Chemotherapy Drug Cancer Chemotherapy Drugs Chemotherapeutic Anticancer Agents Chemotherapeutic Anticancer Drug Chemotherapy Agent, Cancer Chemotherapy Agents, Cancer Chemotherapy Drug, Cancer Chemotherapy Drugs, Cancer Drug, Antineoplastic Drug, Antitumor Drug, Cancer Chemotherapy Drug, Chemotherapeutic Anticancer Drugs, Antineoplastic Drugs, Antitumor Drugs, Cancer Chemotherapy |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta
